We initially focused on RELM-β because of its mitogenic effect on several types of lung cells and especially on PASMCs [12, 14, 29] and its high expression in the pulmonary artery of patients with PAH [14]. The gene discussed is RETNLB; the disease is pulmonary arterial hypertension.